Til­ray cannabis for Vic

Pharmacy Daily - - News -

NAS­DAQ LISTED North Amer­i­can phar­ma­ceu­ti­cal-grade medic­i­nal cannabis pro­ducer Til­ray has an­nounced it has suc­cess­fully ex­ported med­i­cal cannabis from Canada to Aus­tralia to dis­trib­ute to crit­i­cally ill chil­dren.

Til­ray said it will dis­trib­ute its CBD 100 prod­uct to three hos­pi­tals in the state of Vic­to­ria via its whol­ly­owned sub­sidiary Til­ray Aus­tralia New Zealand Pty Ltd.

The prod­ucts are be­ing sup­plied to Royal Chil­dren’s Hos­pi­tal, Monash Chil­dren’s Hos­pi­tal and Austin Health with sup­port from the Gov­ern­ment of Vic­to­ria’s Depart­ment of Health and Hu­man Ser­vices, Vic­to­ria (DHHS), where they will be dis­trib­uted to chil­dren suf­fer­ing from in­tractable epilepsy.

The com­pany first ex­ported medic­i­nal cannabis to Vic­to­ria 18 months ago (PD 06 Mar 2017) for 29 crit­i­cally ill chil­dren through a com­pas­sion­ate ac­cess scheme.

Ac­cord­ing to a Vic­to­rian Gov­ern­ment up­date, in less than one year the scheme “has al­ready helped chil­dren see a re­duc­tion in seizures and has sig­nif­i­cantly im­proved their qual­ity of life.”

Til­ray CBD 100 is an oral so­lu­tion of con­cen­trated cannabi­noid ex­tract with a tar­get con­cen­tra­tion of 100mg/ml CBD in a 25ml vial.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.